In a validation study of 20 patients with PC and 11 healthy subjects, analysis of the exosomal protein biomarkers, glypican-1, and CD63 enabled diagnosis of PC with a sensitivity of 99% and specificity 82% [48]. Here, CD63 is linked to pachyonychia congenita.